Drugs in Context (May 2021)

A non-pharmacological approach to the treatment of urinary tract infections: case reports with Utipro® Plus

  • Tommaso Cai,
  • Cristian Konstantinidis,
  • Sam Ward

DOI
https://doi.org/10.7573/dic.2021-2-2
Journal volume & issue
Vol. 10
pp. 1 – 7

Abstract

Read online

Recurrent urinary tract infections (UTIs) can profoundly impair patients’ quality of life and carry a substantial health resource burden. Although antibiotics are the mainstay of treatment, interest is growing in identifying antibiotic-sparing alternatives. Utipro® Plus is a medical device that acts as a mechanical barrier to protect the intestinal lumen against the adherence and invasion of uropathogenic strains of Escherichia coli. It is intended for the control and prevention of UTIs caused by E. coli and other Gram-negative uropathogens. Using illustrative case reports, this review documents outcomes in three women with recurrent UTIs who were treated with Utipro® Plus in clinical practice.

Keywords